Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03323398 |
|---|---|
| Brief Title: | Dose Escalation and Efficacy Study of mRNA-2416 for Intratumoral Injection Alone and in Combination With Durvalumab for Participants With Advanced Malignancies |
| First Submitted : | October 23, 2017 |
| First Submitted that Met QC Criteria : | October 25, 2017 |
| First Posted : | October 27, 2017 |
| Certification/Extension First Submitted : | July 7, 2022 |
| Certification/Extension First Submitted that Met QC Criteria : | July 7, 2022 |
| Certification/Extension First Posted : | July 11, 2022 |
| Last Update Submitted that Met QC Criteria : | July 7, 2022 |
| Last Update Posted : | July 11, 2022 |